Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Google Scholar 

Olusola P, Banerjee HN, Philley JV, Dasgupta S. Human papilloma Virus-Associated cervical cancer and health disparities. Cells. 2019;8(6).

Kuguyo O, Tsikai N, Thomford NE, et al. Genetic susceptibility for cervical cancer in African populations: what are the host genetic drivers? Omics. 2018;22(7):468–83.

Article  CAS  Google Scholar 

Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer. 2011;15(4):927–35.

Article  Google Scholar 

The Cancer Genome Atlas Research Network. Integrated genomic. Molecular characterization of cervical cancer. Nature. 2017;16(7645):378–84.

Google Scholar 

Lee JE, Chung Y, Rhee S, Kim TH. Untold story of human cervical cancers: HPV-negative cervical cancer. BMB Rep. 2022;55(9):429–38.

Article  CAS  Google Scholar 

Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinf. 2008;29:9:559.

Article  Google Scholar 

Niemira M, Collin F, Szalkowska A et al. Molecular signature of subtypes of non-small-cell lung cancer by large-scale transcriptional profiling: identification of key modules and genes by weighted gene Co-Expression network analysis (WGCNA). Cancers (Basel). 2019;12(1).

Cheng Y, Li L, Qin Z, Li X, Qi F. Identification of castration-resistant prostate cancer-related hub genes using weighted gene co-expression network analysis. J Cell Mol Med. 2020;24(14):8006–17.

Article  CAS  Google Scholar 

Liu J, Wu Z, Sun R, et al. Using mRNAsi to identify prognostic-related genes in endometrial carcinoma based on WGCNA. Life Sci. 2020;1:258:118231.

Article  Google Scholar 

Xing B, Guo J, Sheng Y, Wu G, Zhao Y. Human papillomavirus-negative cervical cancer: A comprehensive review. Front Oncol. 2020;10:606335.

Article  PubMed  Google Scholar 

Joura EA, Giuliano AR, Iversen OE, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med. 2015;19(8):711–23.

Article  Google Scholar 

Yang A, Jeang J, Cheng K, et al. Current state in the development of candidate therapeutic HPV vaccines. Expert Rev Vaccines. 2016;15(8):989–1007.

Article  CAS  Google Scholar 

Small W Jr., Bacon MA, Bajaj A, et al. Cervical cancer: A global health crisis. Cancer. 2017;1(13):2404–12.

Article  Google Scholar 

Yoshihara K, Shahmoradgoli M, Martínez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.

Article  PubMed  Google Scholar 

Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–7.

Article  CAS  Google Scholar 

Yang W, Soares J, Greninger P, et al. Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41(Database issue):D955–961.

CAS  Google Scholar 

Maeser D, Gruener RF, Huang RS. OncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22(6).

Ojesina AI, Lichtenstein L, Freeman SS, et al. Landscape of genomic alterations in cervical carcinomas. Nature. 2014;20(7488):371–5.

Article  Google Scholar 

McIntyre JB, Wu JS, Craighead PS, et al. PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy. Gynecol Oncol. 2013;128(3):409–14.

Article  CAS  Google Scholar 

Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ, Vousden KH. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Lancet. 1992;2(8801):1070–3.

Article  Google Scholar 

Kang S, Kim HS, Seo SS, Park SY, Sidransky D, Dong SM. Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma. Gynecol Oncol. 2007;105(3):662–6.

Article  CAS  Google Scholar 

Zhang J, Ding N, He Y, et al. Bioinformatic identification of genomic instability-associated LncRNAs signatures for improving the clinical outcome of cervical cancer by a prognostic model. Sci Rep. 2021;22(1):20929.

Article  Google Scholar 

Du H, Tang Y, Ren X, et al. A prognostic model for cervical cancer based on ferroptosis-related genes. Front Endocrinol (Lausanne). 2022;13:991178.

Article  PubMed  Google Scholar 

Chen P, Gao Y, Ouyang S, et al. A prognostic model based on Immune-Related long Non-Coding RNAs for patients with cervical cancer. Front Pharmacol. 2020;11:585255.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ventriglia J, Paciolla I, Pisano C, et al. Immunotherapy in ovarian, endometrial and cervical cancer: state of the Art and future perspectives. Cancer Treat Rev. 2017;59:109–16.

Article  CAS  Google Scholar 

Lei X, Lei Y, Li JK, et al. Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy. Cancer Lett. 2020;1:470:126–33.

Article  Google Scholar 

Petitprez F, Meylan M, de Reyniès A, Sautès-Fridman C, Fridman WH. The tumor microenvironment in the response to immune checkpoint Blockade therapies. Front Immunol. 2020;11:784.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rassart E, Desmarais F, Najyb O, Bergeron KF, Mounier C, Apolipoprotein D. Gene. 2020;25:756:144874.

Article  Google Scholar 

Jankovic-Karasoulos T, Bianco-Miotto T, Butler MS, et al. Elevated levels of tumour Apolipoprotein D independently predict poor outcome in breast cancer patients. Histopathology. 2020;76(7):976–87.

Article  Google Scholar 

Hall RE, Horsfall DJ, Stahl J, et al. Apolipoprotein-D: a novel cellular marker for HGPIN and prostate cancer. Prostate. 2004;1(2):103–8.

Article  Google Scholar 

Cury SS, de Moraes D, Freire PP et al. Tumor transcriptome reveals high expression of IL-8 in non-small cell lung cancer patients with low pectoralis muscle area and reduced survival. Cancers (Basel). 2019;11(9).

Ramachandran B. Functional association of oestrogen receptors with HPV infection in cervical carcinogenesis. Endocr Relat Cancer. 2017;24(4):R99–108.

Article  CAS  Google Scholar 

Wang C, Zhang T, Wang K, Zhang S, Sun Q, Yang X. ER-α36 promotes the malignant progression of cervical cancer mediated by Estrogen via HMGA2. Front Oncol. 2021;11:712849.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhai Y, Bommer GT, Feng Y, Wiese AB, Fearon ER, Cho KR. Loss of Estrogen receptor 1 enhances cervical cancer invasion. Am J Pathol. 2010;177(2):884–95.

Article  CAS  Google Scholar 

Bronowicka-Kłys DE, Lianeri M, Jagodziński PP. The role and impact of estrogens and xenoestrogen on the development of cervical cancer. Biomed Pharmacother. 2016;84:1945–53.

Article  Google Scholar 

Zhang Y, Zheng L. Apolipoprotein: prospective biomarkers in digestive tract cancer. Transl Cancer Res. 2020;9(5):3712–20.

Article  CAS  Google Scholar 

Wang Z, Chen H, Sun L, et al. Uncovering the potential of APOD as a biomarker in gastric cancer: A retrospective and multi-center study. Comput Struct Biotechnol J. 2024;23:1051–64.

Article  CAS  Google Scholar